DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jhb52h/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based on public domain information including company URLs.
Key Topics Covered
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. MARKET DRIVERS, TRENDS & ISSUES
- Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies
- Adult Stem Cells Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research
- Adult Stem Cells and Embryonic Stem Cells - A Comparison
- MSCs versus Embryonic or Induced Pluripotent Stem Cells
- MSC Therapies Immune to Ethical Issues Applicable to Embryonic Stem Cells
- MSCs - A Potential Vehicle for 'Targeted Drug Delivery'
- Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements
- Major Challenges Confronting Mesenchymal Stem Cell Market
3. STEM CELL MARKET - A MACRO PERSPECTIVE
4. REVIEW OF SELECT MAJOR STEM CELL VARIANTS
- Adult Stem Cells
- A Low Risk Investment
- Adult Stem Cells Garner More Investments for Research
- Low Versatility - A Major Limiting Factor of Adult Stem Cells
- Hematopoietic Stem Cells - Enjoying Enduring Success
- Restraining Factors
- Induced Pluripotent Stem Cells - An Alternative to ESCs
- A Peek into the Discovery of iPS
- Drug Development - A Major Application for iPS
- Use of iPS for Regenerative Medicine
- Establishing iPS Cell Banks
- Intractable and Congenital Disease Treatments
- Embryonic Stem Cells to Transfigure Medicine
- Ethical Issues and Technical Hurdles Bog Down hESC Research
- Lack of Safety and Efficacy Data - A Key Concern
5. MESENCHYMAL STEM CELL RESEARCH BY APPLICATION
6. PRODUCT OVERVIEW
7. PRODUCT INNOVATIONS/LAUNCHES
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT PLAYERS
10. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Companies Profiled
The report profiles 51 companies including many key and niche players such as:
- Aastrom Biosciences
- Cell Applications
- Celprogen
- Cyagen Biosciences
- EMD Millipore
- Genlantis
- Life Technologies
- Lonza Group
- Mesoblast
- Neuromics
- Osiris Therapeutics
- Orthofix International
- PromoCell
- R&D Systems
- ScienCell Research Laboratories
- Stemcell Technologies
- Stemedica Cell Technologies
- StemGenesis
- Trevigen
- Vitro Biopharma
For more information visit http://www.researchandmarkets.com/research/jhb52h/mesenchymal_stem
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
